HCPLive Network

Self-administered Light Therapy for Cognitive Function after TBI

At-home, daily application of light therapy via light-emitting diodes (LEDs) placed on the forehead and scalp led to improvements in cognitive function and post-traumatic stress disorder in patients with a traumatic brain injury (TBI), according to a groundbreaking study published in Photomedicine and Laser Surgery, a peer-reviewed journal published by Mary Ann Liebert, Inc.

Margaret Naeser, PhD, LAc, VA Boston Healthcare System, Boston University School of Medicine, and colleagues from Massachusetts General Hospital, and Harvard-MIT Division of Health Sciences and Technology, in Boston, and MedX Health Inc. (Mississauga, ON, Canada), report on the use of transcranial LED-based light therapy to treat two patients with longstanding traumatic brain injury (TBI). Each patient applied LEDs nightly and demonstrated substantial improvement in cognitive function, including improved memory, inhibition, and ability to sustain attention and focus. One patient was able to discontinue medical disability and return to full-time work. These cognitive gains decreased if the patients stopped treatment for a few weeks and returned when treatment was restarted. Both patients are continuing LED treatments in the home. The findings are presented in "Improved Cognitive Function After Transcranial, Light-Emitting Diode Treatments in Chronic, Traumatic Brain Injury: Two Case Reports."

Low-level light therapy using lasers or externally placed LEDs to deliver red and near-infrared (NIR) light energy has been shown in cell-based studies to improve cellular metabolism and to produce beneficial physiological effects. In acute stroke in humans, for example, transcranial NIR light therapy applied less than 24 hours post-stroke was associated with improved outcomes.

"The results of this study will provide a basis for future therapeutic use of phototherapy to improve recovery after injury and facilitate management of other CNS disorders. The development of novel therapies to restore function after neurologic injury, stroke, or disease is an increasingly important goal in medical research as a result of an increase in non-fatal traumatic wounds and the increasing prevalence of dementias and other degenerative disorders in our aging population," says Raymond J. Lanzafame, MD, MBA, Editor-in-Chief of the Journal.

 
Source: Mary Ann Liebert, Inc/Genetic Engineering News

Further Reading
Migraines in midlife may be associated with increased odds of developing Parkinson's disease or other movement disorders in later years, according to research published online Sept. 17 in Neurology.
According to an analysis of various scenarios, racial and ethnic factors may contribute to care and behavior in post-spinal cord and brain injury care.
Bodily pain and headache are highly prevalent in pituitary disease, making pain screening and therapy an important part of the work-up for these patients.
Use of electronic medical record systems is associated with considerable loss of free time per clinic day, according to a research letter published online Sept. 8 in JAMA Internal Medicine.
Contrary to standard definitions of autism in play a decade ago, children on the autism spectrum do not have problems with learning language. What they have trouble with is using their language skills in communicating effectively, a new study confirms.
Physicians are often tasked with explaining vaccination safety to concerned parents. Parental fears that routine vaccines can trigger neurological diseases have led to decreasing vaccination rates in some countries and subsequent outbreaks of preventable illnesses. A team of Dutch researchers has debunked the idea that vaccination can cause severe epilepsy
More than one-quarter of hospital medicine services were rated by ordering physicians as at least a partially defensive order, according to a research letter published online Sept. 15 in JAMA Internal Medicine.
More Reading